Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome)

European Heart Journal

Volumn 20, Issue 21, 1999, Pages 1553-1562

  Charbonnier, B ^a   Fotiadis, I ^a   Keltai, M ^a   Leizorovicz, A ^a   Marzilli, M ^a   Masia, R ^a   Moccetti, T ^a   Renard, M ^a   Sadowski, Z ^a   Seabra Gomes, R ^a   Spac, J ^a   Van der Meer, J ^a   Varshavsky, S ^a   Vincent, R ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Low molecular weight heparin; Randomized clinical trial; Unfractionated heparin; Unstable angina

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0032742229     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1879     Document Type: Article

References (25)